Indonesian President Joko Widodo (R) inspects the COVID-19 vaccine trials and production facilities when he visits a state-owned pharmaceutical company at Bandung, in West Java, Indonesia, on Aug. 11, 2020. Indonesian President Joko Widodo has expressed his hope that the third phase of the clinical test on anti-coronavirus vaccine would be completed within six months. The vaccine candidate is currently developed by China-based biopharmaceutical company Sinovac Biotech in partnership with Indonesia's state-owned pharmaceutical holding company PT Bio Farma. (Indonesian Presidential Palace/Handout via Xinhua)
Indonesian President Joko Widodo (C) inspects the COVID-19 vaccine trials and production facilities when he visits a state-owned pharmaceutical company at Bandung, in West Java, Indonesia, on Aug. 11, 2020. Indonesian President Joko Widodo has expressed his hope that the third phase of the clinical test on anti-coronavirus vaccine would be completed within six months. The vaccine candidate is currently developed by China-based biopharmaceutical company Sinovac Biotech in partnership with Indonesia's state-owned pharmaceutical holding company PT Bio Farma. (Indonesian Presidential Palace/Handout via Xinhua)